<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04508062</url>
  </required_header>
  <id_info>
    <org_study_id>B.30.2.ATA.0.01.00/6</org_study_id>
    <nct_id>NCT04508062</nct_id>
  </id_info>
  <brief_title>Effects of the Addition of Uterosacral Ligament Plication to Pectopexy Operation on Anatomical and Subjective Symptoms</brief_title>
  <official_title>Effects of the Addition of Uterosacral Ligament Plication to Pectopexy Operation on Anatomical and Subjective Symptoms in the Treatment of Apical Compartment Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators planned to measure the effectiveness of laparoscopic&#xD;
      pectopexy in apical prolapse and whether the addition of sacrouterine ligaments plication to&#xD;
      pectopexy increases the effectiveness of pectopexy operation. Investigators planned to&#xD;
      measure patients' quality of life using the female sexual function scale test 3, 6 and 12&#xD;
      months after the surgery and to determine how the operation affects the quality of sexual&#xD;
      life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators planned to measure the effectiveness of laparoscopic&#xD;
      pectopexy in apical prolapse and whether the addition of sacrouterine ligaments plication to&#xD;
      pectopexy increases the effectiveness of pectopexy operation. Investigators planned to&#xD;
      measure patients' quality of life using the female sexual function scale test 3, 6 and 12&#xD;
      months after the surgery and to determine how the operation affects the quality of sexual&#xD;
      life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 6, 2019</start_date>
  <completion_date type="Anticipated">July 6, 2021</completion_date>
  <primary_completion_date type="Actual">July 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>questionnaire of lower urinary tract symptoms</measure>
    <time_frame>changes in symptoms for each title at the preoperative day 1 and postoperative day 3 period</time_frame>
    <description>the questionaire examines these titles by scoring from one to ten points:&#xD;
sudden feeling of ürination&#xD;
sudden feeling of urination with incontinence&#xD;
Frequent urination&#xD;
Difficulty of starting the urination&#xD;
Abnormal discharge of urine&#xD;
nocturia&#xD;
dyspareunia&#xD;
Stress urinary incontinence&#xD;
dysuria&#xD;
constipation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>evaluation of sexual function with Women's Sexual Function Index</measure>
    <time_frame>changes at the preoperative day 1 and postoperative day 40 period</time_frame>
    <description>Women's Sexual Function Index is a questionnaire about sexual functions of the women. the index definex sexual functions with some questions and scorings.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stage of apical compartment defect according to the Pelvic Organ Prolapse (POP-Q) classification</measure>
    <time_frame>changes in the stage of apical compartment defect at the preoperative day 1 and postoperative day 3 period according to POP-Q clasification</time_frame>
    <description>Stage of apical compartment defect according to the Pelvic Organ Prolapse (POP-Q) classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of sexual function with Women's Sexual Function Index</measure>
    <time_frame>changes at 3,6 and 12. month after surgery</time_frame>
    <description>Women's Sexual Function Index is a questionnaire about sexual functions of the women. the index definex sexual functions with some questions and scorings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stage of apical compartment defect according to the Pelvic Organ Prolapse (POP-Q) classification</measure>
    <time_frame>changes at 3,6 and 12. month after surgery</time_frame>
    <description>Stage of apical compartment defect according to the Pelvic Organ Prolapse (POP-Q) classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaire of lower urinary tract symptoms</measure>
    <time_frame>changes in symptoms for each title at 3,6 and 12. month after surgery</time_frame>
    <description>the questionaire examines these titles by scoring from one to ten points:&#xD;
sudden feeling of ürination&#xD;
sudden feeling of urination with incontinence&#xD;
Frequent urination&#xD;
Difficulty of starting the urination&#xD;
Abnormal discharge of urine&#xD;
nocturia&#xD;
dyspareunia&#xD;
Stress urinary incontinence&#xD;
dysuria&#xD;
constipation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>pectopexy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>this group will only have pectopexy operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pectopexy and uterosacral ligaments plication group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>this group will have pectopexy operation with bilateral uterosacral ligaments plication</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pectopexy operation</intervention_name>
    <description>Vaginal cuff or uterine cervix will be attached to iliopectineal ligament with polypropylene mesh on both sides.</description>
    <arm_group_label>Pectopexy and uterosacral ligaments plication group</arm_group_label>
    <arm_group_label>pectopexy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>uterosacral ligaments plication operation.</intervention_name>
    <description>At least 2/3 of the sacrouterine ligaments will be shortened with helical sutures, starting from the cervix and so douglas will be partially obliterated.</description>
    <arm_group_label>Pectopexy and uterosacral ligaments plication group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with stage II-IV apical compartment defect according to the POP-Q&#xD;
             classification&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  having severe chronic disease that makes the operation dangerous&#xD;
&#xD;
          -  patients under 25 and patients over 75 years old&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gamze Nur Cimilli Senocak</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ataturk University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gamze Nur Cimilli Senocak</name>
      <address>
        <city>Erzurum</city>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2020</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Gamze Nur Cimilli Şenocak</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>pectopexy</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>uterosacral ligaments plication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

